Morgan Stanley raises target for Thermo Fisher Scientific stock
Published on 10/14/2026 at 13:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalysts lift targets ahead of results
- Morgan Stanley raised its Thermo Fisher target to USD 730.00 on October 13, 2026.
- Second-quarter revenue increased 10.00 percent to USD 11.99 billion on July 23, 2026.
- Thermo Fisher Scientific stock trades at EUR 593.20 at 1:37 p.m. CEST at Lang & Schwarz on October 14, 2026, 0.37 percent above the Xetra close of October 13, 2026.
- Thermo Fisher will publish third-quarter results on October 21, 2026, before the market opens.
Thermo Fisher Scientific stock (ISIN US8835561023) was trading at EUR 593.20 at Lang & Schwarz on October 14, 2026, at 1:37 p.m. CEST, up 0.37 percent from the Xetra close of October 13, 2026, at EUR 591.00. The latest analyst action adds a fresh valuation reference ahead of the company's third-quarter report.
Analysts raise their targets
According to Yahoo Finance on October 13, 2026, Morgan Stanley maintained its Overweight rating and raised its price target from USD 650.00 to USD 730.00. TD Cowen also maintained Buy and lifted its target from USD 675.00 to USD 760.00.
The Morgan Stanley target lies 23.04 percent above the EUR 593.20 Lang & Schwarz price only if currencies are converted, so that comparison is excluded. The separate dollar targets instead show that analysts are reassessing the company's earnings outlook in the run-up to results.
Second-quarter growth sets the bar
The SEC filing dated July 23, 2026, shows second-quarter revenue of USD 11.99 billion, up 10.00 percent from USD 10.85 billion in the year-ago quarter. GAAP diluted earnings per share rose 9.00 percent to USD 4.68, while adjusted earnings per share increased 13.00 percent to USD 6.03.
The same filing reported adjusted operating income of USD 2.735 billion and an adjusted operating margin of 22.80 percent, compared with 21.90 percent a year earlier. The margin expansion and organic revenue growth of 5.00 percent give the October report a higher operational hurdle than the first quarter, when revenue rose 6.00 percent to USD 11.01 billion, according to Fortune.
Three milestones shape the year
On April 23, 2026, Thermo Fisher reported first-quarter revenue of USD 11.01 billion and raised its full-year outlook, according to Fortune. On July 23, 2026, the company reported second-quarter revenue of USD 11.99 billion and adjusted earnings per share of USD 6.03, according to the SEC filing. On October 13, 2026, Morgan Stanley raised its target to USD 730.00, according to Yahoo Finance.
When are the next results due?
Thermo Fisher is scheduled to release third-quarter 2026 results before the market opens on October 21, 2026, and hold its earnings call at 7:00 a.m. ET the same day, according to Thermo Fisher Scientific. The scheduled report will test whether the 5.00 percent organic growth achieved in the second quarter can continue.
Stock trades above the Xetra close
At 1:37 p.m. CEST on October 14, 2026, Thermo Fisher Scientific stock was trading at EUR 593.20 at Lang & Schwarz, 0.37 percent above the Xetra close of October 13, 2026, at EUR 591.00. The primary listing is on the NYSE, where the October 13 session closed at USD 663.04.
The further course of trading is shown by the continuously updated real-time quote of Thermo Fisher Scientific stock.
Thermo Fisher Scientific stock at a glance
- Company: Thermo Fisher Scientific Inc.
- ISIN: US8835561023
- Ticker: TMO
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 14, 2026, 1:37 p.m. CEST): EUR 593.20
- Change versus Xetra close: plus 0.37 percent
- Xetra close (October 13, 2026): EUR 591.00
- Market capitalization: USD 245.2 billion (as of October 13, 2026)
- 52-week range: USD 435.27-694.33 (as of October 13, 2026)
- Sector / Industry: Healthcare / Diagnostics and Research
- Index membership: S&P 500
- Next earnings date: October 21, 2026
Market context: Market report S&P 500.
